Safety of Biologic-DMARDs in Rheumatic Musculoskeletal Disorders: A Population-Based Study over the First Two Waves of COVID-19 Outbreak
Sign Up to like & getrecommendations! Published in 2022 at "Viruses"
DOI: 10.3390/v14071462
Abstract: This study aims to explore disease patterns of coronavirus disease (COVID-19) in patients with rheumatic musculoskeletal disorders (RMD) treated with immunosuppressive drugs in comparison with the general population. The observational study considered a cohort of… read more here.
Keywords: rheumatic musculoskeletal; covid; biologic dmards; musculoskeletal disorders ... See more keywords